ArticleJournal of imaging informatics in medicine2026
Landmark-Based Pancreas Sub-region Segmentation in CT.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
CT-based imaging biomarkers can be derived from the pancreas for detecting pancreatic pathologies. However, current approaches using full pancreas segmentations are unable to provide region-specific biomarkers that are crucial in predicting disease severity for many conditions, such as pancreatic adenocarcinomas. This study aims to develop an automated 3D tool to detect and segment the pancreatic sub-regions (the head, body, and tail) on CT volumes. This retrospective study used a subset of 549 CT volumes from the publicly available TotalSegmentator (TS) dataset. The dataset was randomly split into training (n = 440) and testing (n = 109) subsets. Additionally, 30 CT volumes from the TCIA NIH Pancreas-CT dataset were used for external validation. A 3D full-resolution nnUNet model was trained with a custom loss function to detect the landmarks corresponding to the pancreas's head, body, and tail. Based on the detected landmarks, a post-processing algorithm generated the sub-region segmentations. We evaluated the predicted segmentation against the ground truth masks using the Dice similarity coefficient (DSC) and Normalized Surface Distance (NSD). The mean±std of DSC (%) and NSD (%) for the head, body, and tail were 90.8±4.1 and 94.5±4.6, 83.3±7.6 and 87.2±7.4, and 85.1±9.8 and 89.7±8.8, respectively. On the external dataset, the mean±std of DSC and NSD for the head, body, and tail were 83.4±2.6 and 89.7±4.1, 79.4±5.9 and 88.5±6.0, and 81.2±5.5 and 91.4±5.3, respectively. The proposed model can accurately segment three pancreas sub-regions and enables imaging biomarkers to be derived from each sub-region and the pancreas as a whole.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.